Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients

MLA

Pierre Housset, et al. “Waning but Persistent Humoral Response 6 Months after the Third Dose of the MRNA BNT162b2 Vaccine in Hemodialysis and Peritoneal Dialysis Patients.” Journal of Nephrology, vol. 35, Feb. 2022, pp. 783–85. EBSCOhost, https://doi.org/10.1007/s40620-022-01276-2.

APA

Pierre Housset, Sabah Kubab, Agathe Pardon, Nathalie Vittoz, Dogan-Firat Bozman, Latifa Hanafi, Valérie Caudwell, & Anne-Laure Faucon. (2022). Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patients. Journal of Nephrology, 35, 783–785. https://doi.org/10.1007/s40620-022-01276-2

Chicago

Pierre Housset, Sabah Kubab, Agathe Pardon, Nathalie Vittoz, Dogan-Firat Bozman, Latifa Hanafi, Valérie Caudwell, and Anne-Laure Faucon. 2022. “Waning but Persistent Humoral Response 6 Months after the Third Dose of the MRNA BNT162b2 Vaccine in Hemodialysis and Peritoneal Dialysis Patients.” Journal of Nephrology 35 (February): 783–85. doi:10.1007/s40620-022-01276-2.